Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3057% below fair value
$0.65−0.02 (-2.98%)
Close on Nov 13, 2026Market cap $32.65MP/E –Yield –
Rapid Micro Biosystems r&d expenses
Research and development expenses are spending on new products and technology.
Rapid Micro Biosystems's R&D Expenses for the twelve months ending Jun 30, 2026 was $13.44M, down 3.1% year over year. For fiscal 2025 it was $13.60M, down 6.8% from the year before. The highest annual figure on record is $14.60M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.60M | -6.8% |
| FY2024 | Dec 31, 2024 | $14.60M | +13.9% |
| FY2023 | Dec 31, 2023 | $12.82M | -0.4% |
| FY2022 | Dec 31, 2022 | $12.87M | +31.5% |
| FY2021 | Dec 31, 2021 | $9.78M | +49.8% |
| FY2020 | Dec 31, 2020 | $6.53M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.33M | +3.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.36M | -7.3% |
| Q4 FY2025 | Dec 31, 2025 | $3.22M | -5.3% |
| Q3 FY2025 | Sep 30, 2025 | $3.53M | -2.2% |
| Q2 FY2025 | Jun 30, 2025 | $3.23M | -13.7% |
| Q1 FY2025 | Mar 31, 2025 | $3.62M | -5.7% |
| Q4 FY2024 | Dec 31, 2024 | $3.40M | +2.5% |
| Q3 FY2024 | Sep 30, 2024 | $3.61M | +15.8% |
| Q2 FY2024 | Jun 30, 2024 | $3.74M | +15.8% |
| Q1 FY2024 | Mar 31, 2024 | $3.84M | +21.9% |
| Q4 FY2023 | Dec 31, 2023 | $3.32M | -2.5% |
| Q3 FY2023 | Sep 30, 2023 | $3.12M | +4.8% |
| Q2 FY2023 | Jun 30, 2023 | $3.23M | +9.0% |
| Q1 FY2023 | Mar 31, 2023 | $3.15M | -10.6% |
| Q4 FY2022 | Dec 31, 2022 | $3.40M | +19.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.97M | +21.8% |
| Q2 FY2022 | Jun 30, 2022 | $2.97M | +26.9% |
| Q1 FY2022 | Mar 31, 2022 | $3.53M | +64.2% |
| Q4 FY2021 | Dec 31, 2021 | $2.86M | +75.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.44M | +9.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.34M | +87.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.15M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.63M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.22M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.24M | – |
See a number that looks wrong?